Abstract
Background
The present study was undertaken to investigate the clinical characteristics of hemolytic uremic syndrome (HUS) secondary to cobalamin C disorder (cbl-C disorder).
Methods
We reviewed retrospectively the medical records of 3 children with HUS secondary to cbl-C disorder who had been treated between April 1, 2009 and October 31, 2013.
Results
The 3 patients with HUS secondary to cbl-C disorder presented with progressive hemolytic anemia, acute renal failure, thrombocytopenia, poor feeding, and failure to thrive. Two of the 3 patients once had high blood pressure. The mutations of c.609G>A (p.W203X), c.217C>T (p.R73X) and c.365A>T (p.H122L) in the methylmalonic aciduria (cobalamin deficiency) cbl-C type, with homocystinuria gene were detected in the 3 patients. In these patients the levels of lactate dehydrogenase and homocysteine in serum were elevated and the level of methylmalonic acid (MMA) in urine was also elevated. After treatment with hydroxocobalamin, 2 patients were discharged with no obvious abnormal growth and neurological development and 1 patient died of multiple organ failure.
Conclusions
The results of this study demonstrated that cbl-C disorder should be investigated in any child presenting with HUS. The high concentrations of homocysteine and MMA could be used for timely recognization of the disease. Once the high levels of plasma homocystein and/or plasma or urine MMA are detected, the treatment with parenteral hydroxocobalamin should be prescribed immediately. The early diagnosis and treatment would contribute to the good prognosis of the disease.
Similar content being viewed by others
References
Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 2012;35:91–102.
Weisfeld-Adams JD, Morrissey MA, Kirmse BM, Salveson BR, Wasserstein MP, McGuire PJ, et al. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol Genet Metab 2010;99:116–123.
Weisfeld-Adams JD, McCourt EA, Diaz GA, Oliver SC. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance. Mol Genet Metab 2015;114:537–546.
Tu WJ. Methylmalonic acidemia in mainland China. Ann Nutr Metab 2011;58: 281.
Wang F, Han LS, Hu YH, Yang YL, Ye J, Qiu WJ, et al. Analysis of gene mutations in Chinese patients with methylmalonic acidemia and homocysteinemia. Zhonghua Er Ke Za Zhi 2009;47:189–193. [In Chinese]
Zhang Y, Song JQ, Liu P, Yan R, Dong JH, Yang YL, et al. Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia. Zhonghua Er Ke Za Zhi 2007;45:513–517. [In Chinese]
Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011;6: 60.
Bouts AH, Roofthooft MT, Salomons GS, Davin JC. CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency. Pediatr Nephrol 2010;25:2547–2548.
Kömhoff M, Roofthooft MT, Westra D, Teertstra TK, Losito A, van de Kar NC, et al. Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency. Pediatrics 2013;132:540–544.
Sharma AP, Greenberg CR, Prasad AN, Prasad C. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 2007;22:2097–2103.
Fischer S, Huemer M, Baumgartner M, Deodato F, Ballhausen D, Boneh A, et al. Clinical presentation and outcome in a series of 88 patients with the cblC defect. J Inherit Metab Dis 2014;37:831–840.
Huemer M, Scholl-Bürgi S, Hadaya K, Kern I, Beer R, Seppi K, et al. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy. Orphanet J Rare Dis 2014;9: 161.
Ma X, Zhang Y, Yang Y, Liu X, Yang Z, Bao X, et al. Epilepsy in children with methylmalonic acidemia: electroclinical features and prognosis. Brain Dev 2011;33:790–795.
Huang Z, Han LS, Ye J, Qiu WJ, Zhang HW, Gao XL, et al. Outcomes of patients with combined methylmalonic acidemia and homocystinuria after treatment. Zhonghua Er Ke Za Zhi 2013;51:194–198. [In Chinese]
Ogier de Baulny H, Saudubray JM. Branched-chain organic acidurias. Semin Neonatol 2002;7:65–74.
Wang Y, Chen S, Yao T, Li D, Wang Y, Li Y, et al. Homocysteine as a risk factor for hypertension: a 2-year follow-up study. PLoS One 2014;9: 108223.
Talikoti P, Bobby Z, Hamide A. Hyperhomocysteinemia, Insulin Resistance and High HS-CRP Levelsin Prehypertension. J Clin Diagn Res 2014;8:07–09.
Mesa-Medina O, Ruiz-Pons M, García-Nieto V, León-González J, López-Mendoza S, Solís-Reyes C. Methylmalonic acidemia with homocystinuria. A very rare cause of kidney failure in the neonatal period. Nefrologia 2014;34:539–540.
Gizicki R, Robert MC, Gómez-López L, Orquin J, Decarie JC, Mitchell GA, et al. Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type. Ophthalmology 2014;121:381–386.
Weisfeld-Adams JD, Bender HA, Miley-Åkerstedt A, Frempong T, Schrager NL, Patel K, et al. Neurologic and neurodevelopmental phenotypes in young children with earlytreated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab 2013;110:241–247.
Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes. J Inherit Metab Dis 2012;35:103–114.
Zwickler T, Haege G, Riderer A, Hörster F, Hoffmann GF, Burgard P, et al. Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative? J Inherit Metab Dis 2012;35:797–806.
Davin JC, Buter N, Groothoff J, van Wijk J, Bouts A, Strain L, et al. Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome. Pediatr Nephrol 2009;24:1757–1760.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, QL., Song, WQ., Peng, XX. et al. Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children. World J Pediatr 11, 276–280 (2015). https://doi.org/10.1007/s12519-015-0032-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-015-0032-4